SUNSHINE HEART, INC. and , as Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated as ofWarrant Agreement • March 21st, 2014 • Sunshine Heart, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionThis PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between SUNSHINE HEART, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
MEDICINOVA, INC. and , As Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated As OfWarrant Agreement • November 16th, 2012 • Medicinova Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 16th, 2012 Company Industry JurisdictionPREFERRED STOCK WARRANT AGREEMENT (the “Agreement”), dated as of between MEDICINOVA, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
HORIZON PHARMA, INC. and , As Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated As OfWarrant Agreement • August 1st, 2012 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 1st, 2012 Company Industry JurisdictionPREFERRED STOCK WARRANT AGREEMENT (the “Agreement”), dated as of between HORIZON PHARMA, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
TRIUS THERAPEUTICS, INC. and , As Warrant Agent FORM OF COMMON STOCK WARRANT AGREEMENT Dated As OfWarrant Agreement • September 1st, 2011 • Trius Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 1st, 2011 Company Industry JurisdictionCOMMON STOCK WARRANT AGREEMENT (“Agreement”), dated as of between TRIUS THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
TRIUS THERAPEUTICS, INC. and , As Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated As OfWarrant Agreement • September 1st, 2011 • Trius Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 1st, 2011 Company Industry JurisdictionPREFERRED STOCK WARRANT AGREEMENT (the “Agreement”), dated as of between TRIUS THERAPEUTICS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
ANESIVA, INC. and _________________, As Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated As Of ________________Warrant Agreement • November 13th, 2007 • Anesiva, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 13th, 2007 Company Industry JurisdictionPREFERRED STOCK WARRANT AGREEMENT, dated as of _______ between ANESIVA, INC., a Delaware corporation (the “Company”) and ___________________, a [corporation] [national banking association] organized and existing under the laws of ____________ and having a corporate trust office in ____________, as warrant agent (the “Warrant Agent”).
CORGENTECH INC. and _________________, As Warrant Agent FORM OF PREFERRED STOCK WARRANT AGREEMENT Dated As Of ________________Warrant Agreement • May 5th, 2006 • Corgentech Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 5th, 2006 Company Industry JurisdictionPREFERRED STOCK WARRANT AGREEMENT, dated as of _______ between CORGENTECH Inc., a Delaware corporation (the “Company”) and ___________________, a [corporation] [national banking association] organized and existing under the laws of ____________ and having a corporate trust office in ____________, as warrant agent (the “Warrant Agent”).